Top Markets
#1 Akedo Akedo +62.25%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.06%
#4 Velvet Velvet +40.81%
#5 Black Phoenix Black Phoenix +34.48%
#6 Ο„emplar Ο„emplar +27.84%
#7 Ribbita by Virtuals Ribbita by Virtuals +20.04%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.68%
#9 Bitway Bitway +17.34%
#10 Cap Cap +16.41%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVXA
Kedudukan dalam Saham #38534
Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc... Headquartered in Dublin, Ireland, and established in 1985, Ovoca Bio plc operates as a clinical-stage biopharmaceutical firm dedicated to discovering and bringing to market innovative therapies for various female sexual dysfunctions. Its primary drug candidate, BP-101, is being developed as a medical treatment for premenopausal women diagnosed with hypoactive sexual desire disorder. This compound is presently in Phase II clinical investigation in Australia and New Zealand, and has progressed to Phase III clinical trials within Russia. Beyond its core pharmaceutical work, the company also participates in mineral exploration and offers supplementary support services. The organization, originally incorporated as Ovoca Gold plc, rebranded to Ovoca Bio plc in July 2018.
Harga Saham
$0.01142111
Disegerakkan terakhir: 2025-03-21
Modal Pasaran
$930.66K
Perubahan (1 hari)
0.18%
Perubahan (1 tahun)
0.00%
Negara
IE
Perdagangan Ovoca Bio plc (OVXA)

Kategori

Healthcare
Hasil untuk Ovoca Bio plc (OVXA)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Ovoca Bio plc, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Ovoca Bio plc dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE